{"doi":"10.1016/j.ejca.2018.04.010","title":"MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients","abstract":null,"journal":"European Journal of Cancer","year":2018,"id":46409,"datarank":0.635115975689589,"base_score":4.23410650459726,"endowment":4.23410650459726,"self_citation_contribution":0.635115975689589,"citation_network_contribution":0.0,"self_endowment_contribution":0.635115975689589,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":68,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":2,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":215292,"name":"Selma Ugurel","orcid":null,"position":1,"is_corresponding":false},{"id":215293,"name":"Johanna Mangana","orcid":null,"position":2,"is_corresponding":false},{"id":215294,"name":"Markus Valentin Heppt","orcid":null,"position":3,"is_corresponding":false},{"id":215295,"name":"Thomas Kurt Eigentler","orcid":"0000-0003-0019-2770","position":4,"is_corresponding":false},{"id":215296,"name":"Carola Berking","orcid":null,"position":5,"is_corresponding":false},{"id":5602,"name":"Dirk Schadendorf","orcid":"0000-0003-3524-7858","position":6,"is_corresponding":false},{"id":215297,"name":"Gerold Schuler","orcid":null,"position":7,"is_corresponding":false},{"id":68919,"name":"Reinhard Dummer","orcid":"0000-0002-2279-6906","position":8,"is_corresponding":false},{"id":215298,"name":"Lucie Heinzerling","orcid":null,"position":9,"is_corresponding":false},{"id":215291,"name":"Michael Constantin Kirchberger","orcid":"0000-0002-9573-3009","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients","abstract":"Immune checkpoint inhibition shows comparable response rates in NRAS-mutated and NRAS wildtype melanoma even though survival is less favourable in case of NRAS mutation. Additional MEK inhibition might improve clinical benefit.","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":2,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29843107","pmcid":null,"openalex_id":"https://openalex.org/W29843107","authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0959804918308116?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0959804918308116?httpAccept=text/plain","host_type":"publisher"},{"url":"http://www.theses.fr/1998NAN11019","host_type":""}],"fields_of_study":["Chronic Obstructive Pulmonary Disease (COPD) Research","Medicine"],"mesh_terms":["Humans","Melanoma","Skin Neoplasms","GTP Phosphohydrolases","MAP Kinase Kinase Kinases","Proto-Oncogene Proteins B-raf","Membrane Proteins","Antineoplastic Combined Chemotherapy Protocols","Protein Kinase Inhibitors","Survival Analysis","Retrospective Studies","Mutation","Adult","Aged","Aged, 80 and over","Middle Aged","Female","Male","Young Adult","CTLA-4 Antigen","Antibodies, Monoclonal, Humanized","Programmed Cell Death 1 Receptor","Ipilimumab","Nivolumab"],"keywords":["Physics","Humanities","Medicine","Philosophy","Melanoma","MEK","Ipilimumab","Nras","Nivolumab","Pembrolizumab"],"sdg_mappings":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.16986925.v1","title":"Additional file 1 of Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16986925","title":"Additional file 1 of Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-09T03:15:53.674924Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}